Clinical Practice Guideline for Primary and Secondary Prevention of Stroke.
Full Version
Map
Back - CPG Versions
Help
Download
CPG for Prevention of Stroke
(6,10 Mb)
Table of Contents
Drop down all menus
Roll up all menus
Presentation
Authorship and Collaborations
Key Questions
Summary of Recommendations
Introduction
Scope and Objectives
Methodology
Vascular Risk
4.1. Importance of vascular risk
4.2. Vascular risk factors
4.3. Vascular Risk Estimation Tables
4.4. Vascular Risk Reduction Strategies
Etiological Classification Of Stroke
5.1. What is a stroke?
5.2. Types of stroke
Primary Prevention Of Stroke
6.1. Risk factors
6.2. Non-modifiable risk factors
6.3. Modifiable risk factors
6.4. Lifestyle interventions
6.5. Obesity
6.6. Hypertension
6.7. Diabetes mellitus
6.8. Dyslipemia
6.9. Metabolic syndrome
6.10. Use of oral contraceptives
6.11. Hormone Therapy
6.12. Thrombofilias
6.13. Other related factors and conditions
6.14. Embolic cardiopathies
6.15. Asymptomatic carotid artery stenosis
6.16. Antiaggregant treatment in primary prevention of stroke
6.17. Antithrombotic treatment in pregnant women
6.18. Bleeding risk of anticoagulant treatment
6.19. Subarachnoid hemorrhage
Secondary Prevention Of Stroke
7.1. Risk of a new episode of ischemic stroke or transient ischemic attack
7.2. Lifestyle interventions
7.3. Hypertension
7.4. Dyslipemia
7.5. Hormone Therapy
7.6. Thrombofilias
7.7. Hyperhomocysteinemia
7.8. Embolic cardiopathies
7.9. Symptomatic carotid artery stenosis
7.10. Antithrombotic treatment in secondary prevention of stroke
7.11. Cerebral venous thrombosis
7.12. Antithrombotic treatment after intracerebral hemorrhage
Dissemination And Implementation
Recommendations For Future Research
Annexes
Full list of tables and figures
Bibliography
Latest update: Enero 2009
Copyright
(6,10 Mb) (6,10 Mb)
(6,10 Mb)
